SE508669C2 - Nytt förfarande - Google Patents

Nytt förfarande

Info

Publication number
SE508669C2
SE508669C2 SE9601598A SE9601598A SE508669C2 SE 508669 C2 SE508669 C2 SE 508669C2 SE 9601598 A SE9601598 A SE 9601598A SE 9601598 A SE9601598 A SE 9601598A SE 508669 C2 SE508669 C2 SE 508669C2
Authority
SE
Sweden
Prior art keywords
magnesium
process according
methoxy
hydrogen
alkyl
Prior art date
Application number
SE9601598A
Other languages
English (en)
Swedish (sv)
Other versions
SE9601598L (sv
SE9601598D0 (sv
Inventor
Jan-Aake Hoegberg
Panagiotis Ioannidis
Anders Mattson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20402358&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE508669(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9601598A priority Critical patent/SE508669C2/sv
Publication of SE9601598D0 publication Critical patent/SE9601598D0/xx
Priority to SA97170759A priority patent/SA97170759B1/ar
Priority to TW086104766A priority patent/TW420676B/zh
Priority to ARP970101488A priority patent/AR006640A1/es
Priority to ZA9703153A priority patent/ZA973153B/xx
Priority to TNTNSN97068A priority patent/TNSN97068A1/fr
Priority to MA24558A priority patent/MA24143A1/fr
Priority to DZ970056A priority patent/DZ2209A1/fr
Priority to HR970210A priority patent/HRP970210B1/xx
Priority to UA98105319A priority patent/UA51699C2/uk
Priority to CN97194114A priority patent/CN1100776C/zh
Priority to JP53879697A priority patent/JP4233115B2/ja
Priority to KR10-1998-0708556A priority patent/KR100468331B1/ko
Priority to US08/860,825 priority patent/US6124464A/en
Priority to SI9730402T priority patent/SI0897386T1/xx
Priority to AU27193/97A priority patent/AU711345C/en
Priority to CZ19983398A priority patent/CZ295067B6/cs
Priority to PL97329683A priority patent/PL188824B1/pl
Priority to ES97921045T priority patent/ES2180981T3/es
Priority to AT97921045T priority patent/ATE222904T1/de
Priority to NZ332154A priority patent/NZ332154A/en
Priority to DE69714987T priority patent/DE69714987T2/de
Priority to IL12671697A priority patent/IL126716A/xx
Priority to PT97921045T priority patent/PT897386E/pt
Priority to EE9800363A priority patent/EE03485B1/xx
Priority to EG32297A priority patent/EG23874A/xx
Priority to PCT/SE1997/000674 priority patent/WO1997041114A1/en
Priority to IDP971342A priority patent/ID16685A/id
Priority to HU9901798A priority patent/HUP9901798A3/hu
Priority to DK97921045T priority patent/DK0897386T3/da
Priority to RU98121016/04A priority patent/RU2163238C2/ru
Priority to SK1407-98A priority patent/SK282752B6/sk
Priority to TR1998/02156T priority patent/TR199802156T2/xx
Priority to CA002251636A priority patent/CA2251636C/en
Priority to EP97921045A priority patent/EP0897386B1/en
Priority to BR9708829A priority patent/BR9708829A/pt
Priority to MYPI97001748A priority patent/MY119011A/en
Publication of SE9601598L publication Critical patent/SE9601598L/xx
Priority to YUP-448/98A priority patent/RS49718B/sr
Priority to IS4872A priority patent/IS1984B/is
Priority to NO19984903A priority patent/NO318850B1/no
Publication of SE508669C2 publication Critical patent/SE508669C2/sv
Priority to HK99102051A priority patent/HK1016978A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9601598A 1996-04-26 1996-04-26 Nytt förfarande SE508669C2 (sv)

Priority Applications (41)

Application Number Priority Date Filing Date Title
SE9601598A SE508669C2 (sv) 1996-04-26 1996-04-26 Nytt förfarande
SA97170759A SA97170759B1 (ar) 1996-04-26 1997-03-29 عملية لتحضير ملح ماغنيسيوم لمركب سلفنيل حلقي غير متجانس sulfinyl heterocyclic به استبدال
TW086104766A TW420676B (en) 1996-04-26 1997-04-14 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
ARP970101488A AR006640A1 (es) 1996-04-26 1997-04-14 Procedimiento para la preparacion de una sal de magnesio de un sulfinil-heterociclo substituido
ZA9703153A ZA973153B (en) 1996-04-26 1997-04-14 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle.
TNTNSN97068A TNSN97068A1 (fr) 1996-04-26 1997-04-15 Procede pour la preparation d'un sel de magnesium d'un heterocycle sulfinyle substitue
MA24558A MA24143A1 (fr) 1996-04-26 1997-04-17 Procede pour la preparation d'un sel de magnesium d'un heterocycle sulfinyle substitue.
DZ970056A DZ2209A1 (fr) 1996-04-26 1997-04-20 Procédé pour la préparation d'un sel de magnésium d'un hétérocycle sulfinyle substitué.
HR970210A HRP970210B1 (en) 1996-04-26 1997-04-21 Process for the preparation of magnesium salt of a substituted sulphinil heterocycle
EP97921045A EP0897386B1 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
BR9708829A BR9708829A (pt) 1996-04-26 1997-04-22 Processo para a preparação de um sal de magnesio de um composto heterociclico sulfinil substituido contendo uma porção imidazol sal de magnesio e composição farmaceutica
AT97921045T ATE222904T1 (de) 1996-04-26 1997-04-22 Verfahren zur herstellung des magnesiumsalzes eines substituierten sulphinylheterozyklus
PCT/SE1997/000674 WO1997041114A1 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
JP53879697A JP4233115B2 (ja) 1996-04-26 1997-04-22 置換スルフィニル複素環式化合物のマグネシウム塩の製造法
KR10-1998-0708556A KR100468331B1 (ko) 1996-04-26 1997-04-22 치환된술피닐헤테로사이클의마그네슘염의제조방법
US08/860,825 US6124464A (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulfinyl heterocycle
SI9730402T SI0897386T1 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
AU27193/97A AU711345C (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
CZ19983398A CZ295067B6 (cs) 1996-04-26 1997-04-22 Způsob přípravy hořečnaté soli substituované sulfinylheterocyklické sloučeniny
PL97329683A PL188824B1 (pl) 1996-04-26 1997-04-22 Sposób wytwarzania soli magnezowych podstawionychzwiązków sulfinyloheterocyklicznych
ES97921045T ES2180981T3 (es) 1996-04-26 1997-04-22 Procedimiento para la preparacion de una sal de magnesio de un heterociclo de sulfinilo sustituido.
UA98105319A UA51699C2 (uk) 1996-04-26 1997-04-22 Спосіб одержання магнієвої солі заміщеного сульфінілом гетероциклу
NZ332154A NZ332154A (en) 1996-04-26 1997-04-22 Process for the production of a magnesium salt of a substituted sulphinyl benzimidazole
DE69714987T DE69714987T2 (de) 1996-04-26 1997-04-22 Verfahren zur herstellung des magnesiumsalzes eines substituierten sulphinylheterozyklus
IL12671697A IL126716A (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
PT97921045T PT897386E (pt) 1996-04-26 1997-04-22 Processo para a preparacao de um sal de magnesio de um heterociclo substituido com sulfinilo
EE9800363A EE03485B1 (et) 1996-04-26 1997-04-22 Protsess asendatud sulfinüülheterotsükli magneesiumisoola valmistamiseks
EG32297A EG23874A (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt ofa substituted sulphinyle heterocycle
CN97194114A CN1100776C (zh) 1996-04-26 1997-04-22 制备取代亚磺酰基杂环镁盐的方法
IDP971342A ID16685A (id) 1996-04-26 1997-04-22 Proses pembuatan garam magnesium sulfinil heterolingkar tersubstitusi
HU9901798A HUP9901798A3 (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
DK97921045T DK0897386T3 (da) 1996-04-26 1997-04-22 Fremgangsmåde til fremstilling af et magnesiumsalt af en substitueret sulfinylheterocyklus
RU98121016/04A RU2163238C2 (ru) 1996-04-26 1997-04-22 Способ получения магниевой соли замещенного сульфинил-гетероциклического соединения
SK1407-98A SK282752B6 (sk) 1996-04-26 1997-04-22 Spôsob prípravy horečnatej soli substituovanej sulfinylovej heterocyklickej zlúčeniny
TR1998/02156T TR199802156T2 (xx) 1996-04-26 1997-04-22 �kameli s�lfinil heteroksiklilin magnezyum tuzunun haz�rlanmas� i�lemi.
CA002251636A CA2251636C (en) 1996-04-26 1997-04-22 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
MYPI97001748A MY119011A (en) 1996-04-26 1997-04-23 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
YUP-448/98A RS49718B (sr) 1996-04-26 1998-10-14 Postupak dobijanja magnezijumove soli supstituisanog heterocikličnog sulfinila
IS4872A IS1984B (is) 1996-04-26 1998-10-19 Aðferð til að framleiða magnesíumsalt af útskiptum súlfínýl-heteróhring
NO19984903A NO318850B1 (no) 1996-04-26 1998-10-21 Fremgangsmate for fremstilling av et magnesiumsalt av en substituert sulfinylheterocyklisk forbindelse
HK99102051A HK1016978A1 (en) 1996-04-26 1999-05-07 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601598A SE508669C2 (sv) 1996-04-26 1996-04-26 Nytt förfarande

Publications (3)

Publication Number Publication Date
SE9601598D0 SE9601598D0 (sv) 1996-04-26
SE9601598L SE9601598L (sv) 1997-10-27
SE508669C2 true SE508669C2 (sv) 1998-10-26

Family

ID=20402358

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601598A SE508669C2 (sv) 1996-04-26 1996-04-26 Nytt förfarande

Country Status (40)

Country Link
US (1) US6124464A (sh)
EP (1) EP0897386B1 (sh)
JP (1) JP4233115B2 (sh)
KR (1) KR100468331B1 (sh)
CN (1) CN1100776C (sh)
AR (1) AR006640A1 (sh)
AT (1) ATE222904T1 (sh)
BR (1) BR9708829A (sh)
CA (1) CA2251636C (sh)
CZ (1) CZ295067B6 (sh)
DE (1) DE69714987T2 (sh)
DK (1) DK0897386T3 (sh)
DZ (1) DZ2209A1 (sh)
EE (1) EE03485B1 (sh)
EG (1) EG23874A (sh)
ES (1) ES2180981T3 (sh)
HK (1) HK1016978A1 (sh)
HR (1) HRP970210B1 (sh)
HU (1) HUP9901798A3 (sh)
ID (1) ID16685A (sh)
IL (1) IL126716A (sh)
IS (1) IS1984B (sh)
MA (1) MA24143A1 (sh)
MY (1) MY119011A (sh)
NO (1) NO318850B1 (sh)
NZ (1) NZ332154A (sh)
PL (1) PL188824B1 (sh)
PT (1) PT897386E (sh)
RS (1) RS49718B (sh)
RU (1) RU2163238C2 (sh)
SA (1) SA97170759B1 (sh)
SE (1) SE508669C2 (sh)
SI (1) SI0897386T1 (sh)
SK (1) SK282752B6 (sh)
TN (1) TNSN97068A1 (sh)
TR (1) TR199802156T2 (sh)
TW (1) TW420676B (sh)
UA (1) UA51699C2 (sh)
WO (1) WO1997041114A1 (sh)
ZA (1) ZA973153B (sh)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
ES2222754T3 (es) * 1998-11-18 2005-02-01 Astrazeneca Ab Procedimiento quimico mejorado, y formulacion farmaceutica.
CA2290893C (en) 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
CA2417311C (en) * 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
JP4495465B2 (ja) 2002-03-05 2010-07-07 アストラゼネカ・アクチエボラーグ オメプラゾール及びエソメプラゾールのアルキルアンモニウム塩
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
TW200410955A (en) * 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
EP1556043A1 (en) * 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Amorphous form of esomeprazole salts
US20040242642A1 (en) * 2002-11-18 2004-12-02 Dr. Reddy's Laboratories Limited Crystalline esomeprazole compounds and process for the preparation thereof
WO2004056804A2 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
CA2517714A1 (en) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Polymorphs of s-omeprazole
CL2004000983A1 (es) 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
SE0302382D0 (sv) * 2003-09-04 2003-09-04 Astrazeneca Ab New salts II
SE0302381D0 (sv) 2003-09-04 2003-09-04 Astrazeneca Ab New salts I
ITMI20031813A1 (it) * 2003-09-23 2005-03-24 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di pantoprazolo e suoi sali.
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2246149B1 (es) 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
US20060141054A1 (en) * 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
WO2007146341A2 (en) 2006-06-12 2007-12-21 Teva Pharmaceutical Industries Ltd. Amorphous and crystalline forms of pantoprazole magnesium salt
EP1947099A1 (en) 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Process for solvent removal from omeprazole salts
EP2842953A1 (en) 2007-02-21 2015-03-04 Cipla Limited Process for the preparation of esomeprazole magnesium dihydrate
US8106210B2 (en) * 2007-10-08 2012-01-31 Hetero Drugs Limited Polymorphs of esomeprazole salts
EP2147918A1 (en) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Process for the preparation of S-omeprazole magnesium in a stable form
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
US20110207779A1 (en) * 2010-02-25 2011-08-25 Glenmark Generics Ltd Process for the preparation of esomeprazole magnesium
EP2426111A1 (en) 2010-08-09 2012-03-07 Laboratorios Del. Dr. Esteve, S.A. 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
CN103467453A (zh) * 2013-09-13 2013-12-25 上海海虹实业(集团)巢湖今辰药业有限公司 一种奥美拉唑镁原料药制备方法
CN106397399A (zh) * 2015-07-29 2017-02-15 陕西合成药业股份有限公司 一种泮托拉唑镁的精制方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
FI861772A (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
FI864138A (fi) * 1985-10-16 1987-04-17 Fisons Plc Heterocykliska blandningar.
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
ATE414509T1 (de) * 1994-07-08 2008-12-15 Astrazeneca Ab Aus vielen einzeleinheiten zusammengesetzte tablettierte dosisform

Also Published As

Publication number Publication date
IS4872A (is) 1998-10-19
RU2163238C2 (ru) 2001-02-20
BR9708829A (pt) 1999-08-03
SA97170759B1 (ar) 2006-09-25
ES2180981T3 (es) 2003-02-16
MY119011A (en) 2005-03-31
SI0897386T1 (en) 2002-12-31
KR100468331B1 (ko) 2005-03-16
TR199802156T2 (xx) 1999-02-22
HRP970210B1 (en) 2002-06-30
EE03485B1 (et) 2001-08-15
JP4233115B2 (ja) 2009-03-04
TNSN97068A1 (fr) 1999-12-31
WO1997041114A1 (en) 1997-11-06
HUP9901798A2 (hu) 2000-04-28
NO984903L (no) 1998-10-21
JP2000509067A (ja) 2000-07-18
CA2251636C (en) 2001-04-10
RS49718B (sr) 2007-12-31
AR006640A1 (es) 1999-09-08
MA24143A1 (fr) 1997-12-31
ATE222904T1 (de) 2002-09-15
PL329683A1 (en) 1999-04-12
DE69714987T2 (de) 2003-04-30
CN1216989A (zh) 1999-05-19
EG23874A (en) 2007-11-27
NO318850B1 (no) 2005-05-18
KR20000065018A (ko) 2000-11-06
US6124464A (en) 2000-09-26
YU44898A (sh) 1999-07-28
CZ339898A3 (cs) 1999-03-17
IL126716A (en) 2003-10-31
SE9601598L (sv) 1997-10-27
TW420676B (en) 2001-02-01
CA2251636A1 (en) 1997-11-06
SK282752B6 (sk) 2002-12-03
HUP9901798A3 (en) 2003-02-28
ZA973153B (en) 1997-10-27
IL126716A0 (en) 1999-08-17
IS1984B (is) 2005-02-15
DK0897386T3 (da) 2002-10-28
HRP970210A2 (en) 1998-04-30
EP0897386B1 (en) 2002-08-28
HK1016978A1 (en) 1999-11-12
CZ295067B6 (cs) 2005-05-18
NO984903D0 (no) 1998-10-21
SK140798A3 (en) 1999-04-13
PL188824B1 (pl) 2005-04-29
DZ2209A1 (fr) 2002-12-03
CN1100776C (zh) 2003-02-05
AU711345B2 (en) 1999-10-14
PT897386E (pt) 2002-12-31
NZ332154A (en) 2002-03-01
EP0897386A1 (en) 1999-02-24
SE9601598D0 (sv) 1996-04-26
EE9800363A (et) 1999-04-15
ID16685A (id) 1997-10-30
UA51699C2 (uk) 2002-12-16
DE69714987D1 (de) 2002-10-02
AU2719397A (en) 1997-11-19

Similar Documents

Publication Publication Date Title
SE508669C2 (sv) Nytt förfarande
US7589211B2 (en) Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
EP0874853A1 (en) Process for preparation of cefdinir
EP4046687A1 (en) Method for producing centanafadine
JP4394004B2 (ja) 結晶析出方法
CA2436265A1 (en) 3-(3-amidinophenyl)-5-[({[1-(1-iminoethyl)-4-piperidyl]methyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same
AU711345C (en) Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle
HRP20010767A2 (en) PROCESS FOR PREPARING [S-(R*, S*)]-<F128M>b<F255D>-[[[1-[1-OXO-3-(4-PIPERIDINYL)PROPYL]-3-PIPERIDINYL]CARBONYL]AMINO]-3-PYRIDINEPROPANOIC ACID AND DERIVATIVES
WO2010068049A2 (en) Process for preparing (r)-(+)-lansoprazole and intermediate used therein
MXPA98008790A (en) Process for the preparation of a magnesium salt of a heterocicle of sulfinyl sustitu
Markov et al. Synthesis of substituted 1, 2, 3-triazoles via N-sulfonylaziridines
JP4105821B2 (ja) ジアゾ化合物
SE469894B (sv) Mellanprodukter för framställning av 5-etyl-4-(2-fenoxietyl)- 2H-1,2,4-triazol-3(4H)-on och förfarande för deras framställning
SU464110A3 (ru) Способ получени производных оксиндола или их солей
Moiseev et al. Investigations of 2, 3′-biquinolyl. 7. Thiolation of 1-alkyl-3-(2-quinolyl) quinolinium halides
EP3187494A1 (en) Process for the preparation of pantoprazole sodium sesquihydrate
JPH049379A (ja) 光学活性なオキサジアゾリル―１，４―ジヒドロピリジン化合物の取得方法
NO122700B (sh)
WO2009082344A1 (en) Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a

Legal Events

Date Code Title Description
NUG Patent has lapsed